Pregled bibliografske jedinice broj: 980654
The subtle change in the antivenom purification protocol affects differently intermediates and the final product
The subtle change in the antivenom purification protocol affects differently intermediates and the final product // Annual Meeting of the Croatian Immunological Society - Book of abstracts
Zadar, Hrvatska, 2018. str. 54-54 (poster, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 980654 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The subtle change in the antivenom purification protocol affects differently intermediates and the final product
Autori
Mateljak Lukačević, Sanja ; Kurtović, Tihana ; Brgles, Marija ; Halassy, Beata
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Annual Meeting of the Croatian Immunological Society - Book of abstracts
/ - , 2018, 54-54
Skup
Annual Meeting of the Croatian Immunological Society 2018
Mjesto i datum
Zadar, Hrvatska, 19.10.2018. - 20.10.2018
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
antivenom, purification, caprylic acid
(antivenom ; purification ; caprylic acid)
Sažetak
Animal-derived antibody therapeutics are widely used in medicine for viral and toxin neutralization. Although the various effective manufacturing methodologies have already been implemented into commercial scale production, due to more demanding regulatory requirements there is the constant need for their improvement. One of the major challenges in optimization concerns achieving the final product of high purity in order to ensure its safety and clinical efficiency. Recently, we have established the high yielding protocol for the preparation of snake venom- specific F(ab')2 fragments from hyperimmune horse plasma. The process itself consists of two main phases: caprylic acid selective precipitation of majority of contaminating proteins and pepsin fragmentation of IgG molecules preserved in solution. In the previous research, we have noticed that the most variable part of our refining scheme was caprylic acid fractionation step, thus affecting the purity of the IgG intermediate preparation. Despite the fact that we have succeeded to obtain the F(ab')2- based final product of 100% purity, we aimed for further process improvement regarding its stability by optimizing this critical step. Our goal was to investigate the possible beneficial impact of higher caprylic acid concentration on the IgG fraction composition in order to establish less variable and more reproducible manufacturing process. Here we showed the results indicating that even small variations in operating parameters could cumulatively affect refinement strategy for immunotherapeutics preparation, influencing consequently the quality and, particularly, safety of the final product.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Projekti:
HRZZ-IP-2014-09-4915 - Razvoj održivog procesa prerade antitoksina (ANTI TOX NEW) (Halassy, Beata, HRZZ - 2014-09) ( CroRIS)
Ustanove:
Sveučilište u Zagrebu
Profili:
Marija Brgles
(autor)
Beata Halassy
(autor)
Tihana Kurtović
(autor)
Sanja Mateljak Lukačević
(autor)